| Product Code: ETC6740954 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to rely on imports of cyclosporine, with top exporting countries being Puerto Rico, Metropolitan France, Germany, Spain, and Italy. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. However, the compound annual growth rate (CAGR) from 2020 to 2024 was negative at -2.06%, with a significant decline in growth rate from 2023 to 2024 at -26.63%. This data suggests a challenging market environment for cyclosporine imports into China, potentially influenced by various factors impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cyclosporine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cyclosporine Market Revenues & Volume, 2021 & 2031F |
3.3 China Cyclosporine Market - Industry Life Cycle |
3.4 China Cyclosporine Market - Porter's Five Forces |
3.5 China Cyclosporine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Cyclosporine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 China Cyclosporine Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 China Cyclosporine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Cyclosporine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in China |
4.2.2 Growing awareness about the benefits of cyclosporine in treating various immune system disorders |
4.2.3 Rising healthcare expenditure and improving access to advanced medical treatments in China |
4.3 Market Restraints |
4.3.1 Stringent government regulations and approval process for new drugs in China |
4.3.2 Competition from alternative treatments and therapies |
4.3.3 Potential side effects and risks associated with long-term use of cyclosporine |
5 China Cyclosporine Market Trends |
6 China Cyclosporine Market, By Types |
6.1 China Cyclosporine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Cyclosporine Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Cyclosporine Market Revenues & Volume, By Transplant Rejection Prophylaxis, 2021- 2031F |
6.1.4 China Cyclosporine Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.1.5 China Cyclosporine Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.1.6 China Cyclosporine Market Revenues & Volume, By Autoimmune Myasthenia Gravis, 2021- 2031F |
6.1.7 China Cyclosporine Market Revenues & Volume, By Dry Eye, 2021- 2031F |
6.1.8 China Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Cyclosporine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Cyclosporine Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 China Cyclosporine Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 China Cyclosporine Market Revenues & Volume, By Topical, 2021- 2031F |
6.3 China Cyclosporine Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 China Cyclosporine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Cyclosporine Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 China Cyclosporine Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 China Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Cyclosporine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Cyclosporine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 China Cyclosporine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 China Cyclosporine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 China Cyclosporine Market Import-Export Trade Statistics |
7.1 China Cyclosporine Market Export to Major Countries |
7.2 China Cyclosporine Market Imports from Major Countries |
8 China Cyclosporine Market Key Performance Indicators |
8.1 Patient adherence rate to cyclosporine treatment |
8.2 Number of clinical trials and research studies on cyclosporine in China |
8.3 Adoption rate of cyclosporine in different healthcare facilities |
8.4 Rate of adverse events reported related to cyclosporine therapy |
8.5 Number of new indications or formulations of cyclosporine introduced in the Chinese market |
9 China Cyclosporine Market - Opportunity Assessment |
9.1 China Cyclosporine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Cyclosporine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 China Cyclosporine Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 China Cyclosporine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Cyclosporine Market - Competitive Landscape |
10.1 China Cyclosporine Market Revenue Share, By Companies, 2024 |
10.2 China Cyclosporine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here